Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Better Therapeutics Inc
BTTX
Healthcare
Biotechnology
Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company, which is engaged in developing a software-based novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases (CMDx). Its platform allows for the creation of multiple PDTs that are designed to treat patients with CBT, delivered digitally via an app, to address the underlying...
causes of CMDx. Its lead PDT product candidate, AspyreRx, is a digital behavioral therapeutic delivering CBT for the treatment of a cardiometabolic disease. AspyreRx is a prescription-only digital treatment indicated to provide cognitive behavioral therapy to patients 18 years or older with T2D. The device targets behavior to aid in the treatment of T2D. Its pipeline also includes programs for the treatment of hypertension, hyperlipidemia, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Dysfunction-Associated Steatohepatitis (MASH) and chronic kidney disease.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:BTTX)
New Post
View:
Posts & Comments
Threaded Posts
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 02, 2024 7:15am
Better Therapeutics, Inc. (BTTX): Pioneering Digital Therape
https://beyondspx.com/2024/08/01/better-therapeutics-inc-bttx-pioneering-digital-therapeutics-for-cardiometabolic-diseases/
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 14, 2024 9:41am
BTTX....NR this a.m....not good ; )
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq 2024-03-14 06:38 ET - News Release Company Website: https://www
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 20, 2024 9:50am
BTTX....former $10 S.P.A.C MCAD.....18 cents!!!!
On FDA NR this a.m Something isn't right
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Oct 16, 2023 10:56am
RE:RE:BTTX ....heres another paid Pump...like LQR & PCSA
Tempest.....might have 2 meanings ? Your always sitting on the fence Nibinator Make a f'king call
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 16, 2023 9:55am
BTTX ....heres another paid Pump...like LQR & PCSA
These guys have Zero morals They are paid to lay you out with high priced paper
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 01, 2021 1:40pm
BTTX...... LoL.....should hung on for more than a buck!!
LoL.... I always sell too early ! Cheers !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 01, 2021 1:32pm
BTTX .....scalp #2 on this
Thanks for the dough !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 01, 2021 11:56am
BTTX .....spac runner
Scalped Cheers !
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Creating a Non-Opioid Solution for Chronic Pain Management